| Literature DB >> 34874453 |
Banafsheh Golchoubian1,2, Andreas Brunner1, Helena Bragulat-Teixidor1, Annett Neuner1, Busra A Akarlar3, Nurhan Ozlu3, Anne-Lore Schlaitz1,2.
Abstract
Nuclear pore complexes (NPCs) are channels within the nuclear envelope that mediate nucleocytoplasmic transport. NPCs form within the closed nuclear envelope during interphase or assemble concomitantly with nuclear envelope reformation in late stages of mitosis. Both interphase and mitotic NPC biogenesis require coordination of protein complex assembly and membrane deformation. During early stages of mitotic NPC assembly, a seed for new NPCs is established on chromatin, yet the factors connecting the NPC seed to the membrane of the forming nuclear envelope are unknown. Here, we report that the reticulon homology domain protein REEP4 not only localizes to high-curvature membrane of the cytoplasmic endoplasmic reticulum but is also recruited to the inner nuclear membrane by the NPC biogenesis factor ELYS. This ELYS-recruited pool of REEP4 promotes NPC assembly and appears to be particularly important for NPC formation during mitosis. These findings suggest a role for REEP4 in coordinating nuclear envelope reformation with mitotic NPC biogenesis.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34874453 PMCID: PMC8656412 DOI: 10.1083/jcb.202101049
Source DB: PubMed Journal: J Cell Biol ISSN: 0021-9525 Impact factor: 8.077
Figure 1.A pool of REEP4 localizes to the INM. (A and B) HeLa cells with genomically HA-tagged REEP4 immunolabeled for HA. (A) Costained for Reticulon 4. (B) Costained for the ER marker Calnexin and the INM marker Lamin B1. Nuclear rim signal is detected for all three proteins after Triton X-100 treatment, but only for Calnexin after digitonin permeabilization. (C) HEK293T cells expressing the ONM marker GFP-Nesprin1α were fractionated into nuclei and cytoplasm. Left: Nuclei treated with agarose-coupled or unmodified (free) proteinase K and analyzed by immunoblotting. Right: In the cytoplasmic fraction, agarose-proteinase K degraded REEP4 but not the ER luminal protein GRP94, suggesting that ER integrity is maintained. (D) TEV cleavage assay: Purified NusA-TEV cleaves only cytoplasmic HA tags, while nucleoplasmic HA tags are protected. V5 tags mark cells expressing the reporter. (E and F) NusA-TEV cleavage assays were performed on HeLa cells expressing REEP4-V5-tev-HA (E) or REEP3-V5-tev-HA (F). Cells were immunostained for the V5 tag, the HA tag, and Lamin A/C to identify the nuclear rim. In A, B, E, and F, scale bars are 10 µm. In E and F, asterisks indicate untransfected cells.
Figure 2.REEP4 BioID experiment identifies ELYS. (A) NusA-TEV cleavage assay on HeLa cells expressing REEP4-TurboID-V5-tev-HA reveals that REEP4-TurboID-V5-tev-HA localizes to peripheral ER and INM like endogenous REEP4. Asterisks indicate untransfected cells. (B) Scheme for REEP4-BioID with controls. (C) HEK cells were induced for expression of the indicated TurboID constructs for 24 h and treated with biotin for 1 h before fixation. TurboID constructs were detected with an HA antibody, and biotinylated proteins with fluorescently labeled streptavidin. (D) Proteins identified as proximal to REEP4 with fivefold or larger enrichment in REEP4 over control samples. See Table S1 for full list, raw MS datasets, and enrichment of proteins in REEP4 sample over single control samples. (E–G) REEP4-HA cells immunolabeled for the HA tag and ELYS and imaged by STED microscopy. (H) Quantification of REEP4 fraction in the vicinity of NPCs; ELYS included as a control. Scale bars are 10 µm (A and C), 5 µm (E), 500 nm (F), and 200 nm (G).
Figure 3.ELYS promotes REEP4 INM targeting. (A) REEP4-HA cells treated with control or ELYS-targeting siRNA; labeled for the HA tag, ELYS, and Lamin B1; and imaged by confocal microscopy. Arrowheads indicate the nuclear rim. (B–D) NusA-TEV assay of HeLa cells expressing REEP4-V5-tev-HA, treated with control or ELYS siRNA, and stained for V5 tag, HA tag, and Lamin A/C. (B) Representative images. Asterisks indicate untransfected cells. (C) Quantification of cells with HA staining at the nuclear rim after NusA-TEV treatment (n = 5). (D) For an estimate of changes to the fraction of REEP4 at the nuclear rim, HA signal intensity (i.e., INM pool) was divided by V5 signal intensity (i.e., total pool of REEP4), and the mean value was normalized to the HA/V5 ratio in the respective control. n = 5 with 25 cells analyzed per condition. (E and F) Fraction of REEP4-V5-tev-HA–expressing, NusA-TEV–treated cells with HA staining at the nuclear rim in control cells or after depletion of Nup153 (E; average of two experiments with very similar outcomes) or LBR (F; n = 3). In A and B, scale bar is 10 µm. In C, E, and F, ≥35 cells were analyzed per condition in a blinded manner. In C, D, and F, error bars are SEM. P values were obtained using two-tailed, paired t tests. See Fig. S1, A–D, for analysis of ELYS, Nup153, and LBR depletions and expression of REEP4-V5-tev-HA.
Figure S1.Role of ELYS in REEP4 INM targeting. Related to Fig. 3. (A) Cells transfected with a construct for expression of REEP4-V5-tev-HA and with control, ELYS-, Nup153-, or LBR-targeting siRNA were lysed in Laemmli buffer and analyzed by SDS-PAGE and immunoblotting using an antibody against REEP4, which detects both endogenous REEP4 and REEP4-V5-tev-HA. Expression of REEP4-V5-tev-HA was not reduced after either of the siRNA treatments. (B–D) Lysates of cells transfected for the TEV assays with nontargeting control and ELYS- (B), Nup153- (C), or LBR- (D) targeting siRNA were analyzed by SDS-PAGE and immunoblotting with antibodies against the respective depleted proteins. (B and C) ELYS (n = 4) and Nup153 (n = 2) protein levels were on average reduced by 70%. (D) LBR protein levels were on average reduced by 90% (n = 3). (A–D) Images below the immunoblots show total protein stain of the membrane to visualize the amounts of loaded protein in the different samples. The total protein amounts in the respective lanes were used for normalization before determining depletion efficiency. (E) HeLa cells were treated with control or ELYS siRNA and immunostained for ELYS and the INM proteins Lamin A/C, SUN2, Emerin, and LBR. After ELYS-specific RNAi, ELYS was markedly reduced at the nuclear rim (far left column) but localization of the INM proteins Lamin A/C, SUN2, and Emerin was not impaired. Lamin A/C staining appeared increased after ELYS depletion for unknown reasons. Note that the two left columns show the same cells for control and ELYS RNAi, respectively, that were labeled for both ELYS and Lamin A/C. LBR targeting to the INM was impaired after ELYS depletion (far right column), as previously described by Mimura et al. (2016). Scale bar is 20 µm. (F) Cells expressing the INM protein Lap2β tagged N-terminally with HA-tev-V5 were treated with control or ELYS-targeting siRNAs and subjected to NusA-TEV treatment. Only the NusA-TEV treatment condition is shown; buffer-treated cells show an identical pattern. At least 30 cells were analyzed per condition in two different experiments. All control cells with V5-labeling, indicating successful transfection, also showed HA-staining of corresponding intensity. Among 68 V5-positive ELYS RNAi cells, one cell was lacking clear HA staining, but all other cells showed HA staining that corresponded to V5 intensity, suggesting that ELYS depletion did not lead to increased permeability of NPCs for NusA-TEV protease. Scale bar is 10 µm.
Figure 4.REEP4 is required for normal NPC densities. (A–C) HeLa cells treated with control or REEP4 siRNA, immunolabeled for indicated nucleoporins, and imaged by confocal microscopy. (A) Representative images. Arrowheads indicate cells with increased nucleoplasmic ELYS foci. (B) Mean intensities of the respective nuclear rim proteins in control and depleted cells. Lamin B1 (LMNB1), Lamin A/C (LMNAC), n = 3; ELYS, RanBP2, n = 4; FG-Nups, n = 6. At least 100 cells were analyzed per condition. Error bars are SEM. Two-sided, paired t tests were performed on the raw data and yielded the indicated P values. (C) Percentage of cells with zero, one to three, or four or more intranuclear ELYS foci in control and REEP4 RNAi cells. n = 3; ≥55 cells were analyzed per condition in a blinded manner; error bars are SEM. (D–G) Transmission EM analysis of control and REEP4 RNAi cells. (D and F) Overview images. (E) Enlarged views of the regions marked as 1 and 2 in D. Arrows indicate examples of rare NPC intermediates in the ER of control cells. (G) Images of consecutive serial z-sections (z1–z6) of the region outlined in F, showing clustered NPC intermediates in stacked ER cisternae in the cell periphery in REEP4 RNAi cells. See Fig. S2 G for another example. Scale bars: 20 µm (A), 1 µm (D and F), 100 nm (E and G).
Figure S3.Further characterization of the role of REEP4 in mitotic NPC assembly. Related to Fig. 5. (A) Two examples for ELYS signal mean intensity changes in G1 versus G2 after REEP4 RNAi. These are two of the eight experiments that were incorporated into Fig. 5 B but showing the raw data without normalization to the G1 or G2 controls. (B and C) Quantification of NPC numbers per surface area in control and REEP4-depleted HeLa cells in G1 cells (identified by low CENP-F signal) expressing endogenously GFP-tagged Nup107 (Otsuka et al., 2016) and immunostained for GFP or ELYS. (B) Representative images. Red outline marks mask generated for particle counting in the two nuclei. Scale bar is 5 µm. (C) NPC densities were determined by particle counting of ELYS- or Nup107-positive NPC-sized structures at the nuclear surface in control and REEP4-depleted cells and normalized to control conditions. At least eight cells were analyzed per condition in each experiment. ELYS: n = 4; error bars are SEM. A two-sided t test for unequal variance was performed on the normalized data. Nup107: average of two experiments with very similar outcomes is shown. (D and E) Quantification of the cytoplasmic pool of the nucleoporin RanBP2 in control and REEP4-depleted HeLa G1 cells. (D) Representative images. Scale bar is 20 µm. (E) Mean signal intensity of RanBP2 in the cytoplasm in REEP4 RNAi cells relative to control. At least 80 cells were analyzed per condition in each experiment. (C and E) Shown are the means from three experiments. Error bars are SEM. A one-sided, unequal variance t test was performed on normalized data. (F) Western blot analysis of REEP4 and ELYS depletion in experiments shown in Fig. 5, C and D. ELYS was depleted by ∼85% and REEP4 by ∼90% in both single- and double-depletion experiments (average of two experiments).
Figure S2.Characterization of the REEP4 depletion phenotype. Related to Fig. 4. (A) HeLa cells were transfected with control siRNA or REEP4 siRNAs #2 and #3 (REEP4 siRNA #1 is used in all other experiments), fixed, immunolabeled for ELYS, and imaged by confocal microscopy. Mean intensities at the nuclear rim were measured in control and REEP4 RNAi cells from the microscopy images. At least 100 cells were analyzed per condition; shown are the normalized mean intensities obtained in three experiments (dots). The horizontal line indicates the mean of the three experiments. Welch’s t test was performed on normalized data. For REEP4 siRNA #3, the P value is larger than 0.05; however, in each single experiment, ELYS levels are reduced compared with the control. We therefore conclude that ELYS reduction at the nuclear rim is a specific effect of REEP4 depletion. (B and C) Whole lysates of HeLa cells depleted of REEP4 using the indicated siRNAs were analyzed by SDS-PAGE and Western blotting and probed for REEP4 (B) or ELYS (C). To indicate amounts of loaded proteins, either actin (B) or total protein (C) was visualized. (D–F) Empty HA-tagging vector or RNAi-resistant, HA-tagged wild-type REEP4 was expressed in control cells or REEP4 RNAi cells, fixed, immunolabeled for ELYS, and imaged by confocal microscopy. (D) ELYS mean intensity at the nuclear rim was measured in transfected cells identified by expression of cotransfected RFP-KDEL (this transfection marker was used because the empty HA-tagging vector control does not yield an HA signal in transfected cells). Results of eight experiments are shown; ≥100 cells were analyzed per condition. Error bars are SEM. (E) Western blot analysis of lysates from cells used for experiment described in D. The lanes correspond to the bars of the graph directly above. Endogenous REEP4 and REEP4-HA were detected with anti-REEP4 antibody; actin served as a loading control. (F) Example images from experiment analyzed in E and D. In cells depleted of endogenous REEP4 and expressing REEP4-HA, ELYS levels at the nuclear rim are restored. However, in the entire population, REEP4-HA is not expressed to the same levels as endogenous REEP4 (see E) and only partially rescues the REEP4 RNAi phenotype (see D). Scale bar is 20 µm. (G) Additional example for transmission EM analysis of REEP4 RNAi phenotype as in Fig. 4, F and G. Left: Overview image. Right: Images of consecutive serial z-sections of the regions outlined in blue and green in the overview image. Scale bars: overview 1 µm, serial sections 100 nm.
Figure 5.REEP4 promotes mitotic NPC formation. (A–C) HeLa cells treated with control siRNA or depleted of REEP4 (A and B) or ELYS and ELYS/REEP4 (C and D), immunolabeled for indicated nucleoporins and CENP-F (A and B), and imaged by confocal microscopy. (A and C) Representative images. (A) Arrowheads indicate cells with low CENP-F signal. (B and D) Mean intensities of the respective nucleoporins at the nuclear rim. (B) Mean intensities were measured in either G1 cells (low CENP-F) or G2 cells (high CENP-F signal). Nucleoporin levels shown are relative to the respective control (G1 or G2). ELYS, n = 8; RanBP2, n = 10; gp210, n = 4; ≥21 cells analyzed per G1 or G2 condition. (D) n = 4. At least 100 cells were analyzed per condition. See Fig. S3 F for analysis of ELYS and REEP4 depletion efficiency. (B and D) Error bars are SEM. Two-sided, paired t tests were performed on the raw data. (E) REEP4-HA cells in anaphase, immunolabeled for ELYS and the HA tag (to detect REEP4), KDEL (general ER), REEP5, or RTN4 (both markers of high curvature ER), and imaged by confocal microscopy. Arrowheads indicate chromosomal noncore regions with accumulated ELYS. Scale bars: 20 µm (A and C), 5 µm (E).
siRNAs used in this study
| Name | Catalogue number; si RNAi ID | Sequence (5′ to 3′) |
|---|---|---|
| REEP4 siRNA#1 | AM16708; 32438 | GGCUGUGAAGACCAAGAACTT |
| REEP4 siRNA#2 | 4392420; s37272 | GCAGAGAUCGUUACAGACATT |
| REEP4 siRNA#3 | 4392420; s37270 | CAAGAACAUUCGUGAAUAUTT |
| ELYS siRNA | AM16708; 108720 | GGUCUCCUCAACGACUUAATT |
| LBR siRNA | 4392420; s8101 | GCCUCUUAUUGAUGGAAGATT |
| Nup153 siRNA | 4392420; s19375 | GCAUCGCCGAAGAUAGAUUTT |
| Negative control siRNA | AM4611 | Not disclosed by manufacturer |
Primers and oligonucleotides used in this study
| Name | Sequence (5′ to 3′) | Purpose |
|---|---|---|
| M1-REEP4 | CTCATGCTGTGCCTCCCCTTTCCCCAGGGCACCTCGCGCTCCCTGAAGGTTCGGACGAGGAAAAAGACTGTGCCCTCAGACGTGGACAGCTCAGGTGGAGGAGGTAGTG | Generation of amplicon for HA-tagging of REEP4 at the endogenous locus with CRISPR/Cas12 ( |
| M2-REEP4 | ATAGCCCTGGAGCCCTGCAGGGCACGAGGTAAGAAGGGGGCAGATGCAGCAGACCAAAAAATGGACAGCTAGGGTCTGCTGATCTACAAGAGTAGAAATTAGCTAGCTGCATCGGTACC | Generation of amplicon for HA-tagging of REEP4 at the endogenous locus with CRISPR/Cas12 ( |
| RGP09 | AGATACTGAGGCAGTCCCCC | Forward primer for sequencing of gene-edited REEP4 locus |
| RGP10 | GACTTTCCACACCGTCGACAT | Reverse primer for sequencing of gene-edited REEP4 locus |
| oAS363 | GCCCTGAAAATAAAGATTCTCTGTTGTGGGTCCACTACCAGATCCGGAGCTGTCCACGTCTGAGGGCAC | Generation of REEP4-V5-tev-HA (see text) |
| oAS365 | TCTTTATTTTCAGGGCAGTGGTAGTGGCAGCGGATACCCATACGATGTTCCAGATTAC | Generation of REEP4-V5-tev-HA (see text) |
| oAS416 | TCCGAGCAGGGGATTGGGGATAGGCTTGCCTCCACTACCAGATCCGGAGC | Generation of REEP4-V5-tev-HA (see text) |
| oAS417 | AATCCCCTGCTCGGACTGGATAGCACCCCCACAACAGAGAATCTTTATTTTC | Generation of REEP4-V5-tev-HA (see text) |
| oAS421 | TCCGGATCTGGTAGTGGAGGCAAGCCTATCCCCAATCCCCTGCTCGGACTGGATAGCACCCCCACAACAGAGAATCTTTATTTTCAGGGC | Generation of REEP3-V5-tev-HA (see text) |
| oAS422 | GCCCTGAAAATAAAGATTCTCTGTTGTGGGGGTGCTATCCAGTCCGAGCAGGGGATTGGGGATAGGCTTGCCTCCACTACCAGATCCGGA | Generation of REEP3-V5-tev-HA (see text) |
| oAS423 | CACTACCAGATCCGGAAAAATACACTTGTGGTCGTTTCTTC | Generation of REEP3-V5-tev-HA (see text) |
| oAS424 | AATCTTTATTTTCAGGGCAGTGGTAGTGGCAGCGGATACCCATACGATGTTCCAGATTAC | Generation of REEP3-V5-tev-HA (see text) |
| oAS492 | AGTGGTAGTGGCAGCGGACCCACAACAGAGAATCTTTATTTTCAGGGCGGCAAGCCTATCCCCAATCCCCTGCTCGGACTGGATAGCACCTCCGGATCTGGTAGTGGA | Generation of HA-tev-V5-Lap2β (see text) |
| oAS493 | TCCACTACCAGATCCGGAGGTGCTATCCAGTCCGAGCAGGGGATTGGGGATAGGCTTGCCGCCCTGAAAATAAAGATTCTCTGTTGTGGGTCCGCTGCCACTACCACT | Generation of HA-tev-V5-Lap2β (see text) |
| oAS494 | GCTGCCACTACCACTAGCGTAATCTGGAACATCGTATGGGTACATGGTGGCGACCGGTAGC | Generation of HA-tev-V5-Lap2β (see text) |
| oAS495 | CGGATCTGGTAGTGGAATGCCGGAGTTCCTAGAGGAC | Generation of HA-tev-V5-Lap2β (see text) |
| AB20 | GGCAGCGGATCCGGGTCTGGCTCCGGATCAAAAGACAATACTGTGCCTCTGAAGC | Amplification of TurboID sequence |
| AB21 | CTATGCGTAATCCGGTACATCGTAAGGGTAGCTAGCCTTTTCGGCAGAC | Amplification of TurboID sequence |
| AB03 | ATGTACCGGATTACGCATAGTGTACAAGTAAAGCGGCCGC | Amplification/linearization of REEP4-HA–containing vector |
| AB15 | CCAGACCCGGATCCGCTGCCGCTGTCCACGTCTGAGGG | Amplification/linearization of REEP4-HA–containing vector |
| AB22 | CGGACTCAGATCTCGAGCTCATGTCTGCGGCCATGAG | Amplification of REEP5 sequence |
| AB23 | CCAGACCCGGATCCGCTGCCGGTGCTCTTCTTTTCTTCACCC | Amplification of REEP5 sequence |
| AB24 | ATGTACCGGATTACGCATAGTGTACAAGTAAAGCGGCCGC | Amplification of REEP4-HA vector backbone (excluding REEP4-HA) |
| AB25 | GAGCTCGAGATCTGAGTCCG | Amplification of REEP4-HA vector backbone (excluding REEP4-HA) |
| AB26 | AGAAATCAGTCTGCGGTCTGC | Amplification of vector backbone (from 3xHA-miniturbo-NLS; Addgene) |
| AB27 | TGCGTAGTCTGGGACGTC | Amplification of vector backbone (from 3xHA-miniturbo-NLS; Addgene) |
| AB28 | ATGACGTCCCAGACTACGCAAAAGACAATACTGTGCCTCTGAAGC | Amplification of TurboID-NLS |
| AB29 | CTTTTCGGCAGACCGCAG | Amplification of TurboID-NLS |
| AB08 | CTAGAGGGCCCGTTTAAACC | Amplification/linearization of pcDNA5/FRT/TO vector |
| AB09 | CAAGCTTAAGTTTAAACGCTAGAGTCC | Amplification/linearization of pcDNA5/FRT/TO vector |
| AB10 | AGCGTTTAAACTTAAGCTTGATGGTGTCCTGGATGATCTGTC | Amplification of REEP4-TurboID-HA |
| AB11 | GGTTTAAACGGGCCCTCTAGCTATGCGTAATCCGGTACATCG | Amplification of REEP4- and REEP5-TurboID-HA |
| AB30 | AGCGTTTAAACTTAAGCTTGATGTCTGCGGCCATGAG | Amplification of REEP5-TurboID-HA |
| AB32 | GGTTTAAACGGGCCCTCTAGCCTCTAGATGCATGCTCGAGTC | Amplification of HA-TurboID-3xNLS |
| AB33 | AGCGTTTAAACTTAAGCTTGTACCCCTATGACGTCCCAGACTACGCAAAAGACAATAC | Amplification of HA-TurboID-3xNLS |
Primary antibodies used in this study
| Target (clone) | Source/reference and catalogue number | Host species | Dilutions used |
|---|---|---|---|
| HA tag (6E2) | CST, 2367 | Mouse | IF: 1/100 |
| GFP | Roche, 11814460001 | Mouse | WB: 1/5,000; IF: 1/500 |
| HA tag (3F10) | Sigma-Aldrich, 11867423001 | Rat | WB: 1/5,000 |
| Reticulon4 | Abcam, ab47085 | Rabbit | IF: 1/250 |
| Calnexin | Abcam, ab22595 | Rabbit | IF: 1/250 |
| REEP4 |
| Rabbit | WB: 1/1,000 |
| Lamin B1 | Abcam, ab16048 | Rabbit | IF: 1/500 |
| ELYS | Sigma-Aldrich, HPA031658 | Rabbit | IF: 1/200; WB: 1/1,000 |
| FG Nups (Mab414) | BioLegend, 902901 | Mouse | IF: 1/2,000 |
| RanBP2 |
| Goat | IF: 1/4,000 |
| Lamin A/C | Santa Cruz, sc-6215 | Goat | IF: 1/100 |
| V5 tag | CST, 13202 | Rabbit | IF: 1/1,000 |
| GRP94 (9G10) | Stressgen, SPA-850 | Rat | WB: 1/1,000 |
| SUN2 | Abcam, ab124916 | Rabbit | IF: 1/100 |
| Emerin | Proteintech, 10351-AP | Rabbit | IF: 1/250 |
| LBR | Abcam, ab32535 | Rabbit | IF: 1/100; WB: 1/1,000 |
| Nup153 | Abcam, ab84872 | Rabbit | WB: 1/1,000 |
| actin | Abcam, ab8224 | Mouse | WB: 1/1,000 |
| CENP-F | BD Transduction Laboratories, 610768 | Mouse | IF: 1/100 |
| gp210 | Bethyl Laboratories | Rabbit | IF: 1/100 |
| KDEL | Enzo, ADI-SPA-827 | Mouse | IF: 1/100 |
| Lamin B1 (CoraLite 647 conjugate) | Proteintech, CL647-66095 | Mouse | IF: 1/100 |
IF, immunofluorescence; WB, Western blotting.
Secondary antibodies and reagents for detection of biotinylated proteins used in this study
| Conjugation | Target species | Host species | Source and catalogue number | Dilutions used |
|---|---|---|---|---|
| IRDye 800CW | Rabbit | Goat | Licor, 926-32211 | WB: 1/10,000 |
| IRDye 680D | Mouse | Goat | Licor, 926-68070 | WB: 1/10,000 |
| Alexa Fluor 680 | Rat | Goat | Thermo Fisher Scientific, A-21096 | WB: 1/10,000 |
| Alexa Fluor 488 | Rabbit | Donkey | Thermo Fisher Scientific, A21206 | IF: 1/500 |
| Alexa Fluor 488 | Mouse | Donkey | Thermo Fisher Scientific, A21202 | IF: 1/500 |
| Alexa Fluor 647 | Rabbit | Donkey | Thermo Fisher Scientific, A31573 | IF: 1/500 |
| Alexa Fluor 647 | Mouse | Donkey | Thermo Fisher Scientific, A31571 | IF: 1/500 |
| Alexa Fluor 568 | Rabbit | Donkey | Thermo Fisher Scientific, A10042 | IF: 1/500 |
| Alexa Fluor 568 | Mouse | Donkey | Thermo Fisher Scientific, A10037 | IF: 1/500 |
| STAR 635P | Rabbit | Goat | Abberior, ST635P-1002 | IF (STED): 1/200 |
| ATTO 594 | Mouse | Goat | Sigma-Aldrich, 76085 | IF (STED): 1/200 |
| Alexa Fluor 647–streptavidin | NA | NA | Thermo Fisher Scientific, S21374 | IF: 1/2,000 |
| DyLight800-streptavidin | NA | NA | Thermo Fisher Scientific, 21851 | WB: 1/15,000 |
IF, immunofluorescence; NA, not applicable; WB, Western blotting.